About this Research Topic
Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021
This Research Topic is part of the Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021 series.
Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021
Methods and Application in Cardiovascular and Smooth Muscle Pharmacology: 2021
Methods and Application in Integrative and Regenerative Pharmacology: 2021
Methods and Application in Drug Metabolism and Transport: 2021
Methods and Application in Predictive Toxicology: 2021
Please submit your article to the Research Topic that best suits the focus of your research.
Introduction and general guidelines
This series aims to highlight the latest experimental techniques and methods used to investigate fundamental questions in Pharmacology of Anti-Cancer Drugs research from drugs targeting tumor cells to components of the tumor microenvironment, including non-tumor cells (e.g., endothelial cells, macrophages, lymphocytes, and fibroblasts), and stress conditions such as hypoxia and acidity. This collection may include the synergy between chemotherapy and targeted therapies including immunotherapies (e.g. CAR-T cells); the use of nanoscale particles or targeting moieties to improve drug bioavailability; the role of extracellular vesicles, liquid biopsies as platelets; the identification of biomarkers derived from proteomics, genomics or imaging technologies to predict response or resistance to drug treatment. Review articles or opinions on methodologies or applications including the advantages and limitations of each are welcome. This Topic includes technologies and up-to-date methods which help advance science.
The contributions to this collection will undergo peer-review. Novelty may vary, but the utility of a method or protocol must be evident. We welcome contributions covering all aspects of Pharmacology of Anti-Cancer Drugs. Submissions will be handled by the team of Topic Editors in the respective sections.
Frontiers in Pharmacology supports the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles for scientific data management and stewardship (Wilkinson et al., Sci. Data 3:160018, 2016).
This Research Topic welcomes:
• Methods: Describing either new or existing methods that are significantly improved or adapted for specific purposes. These manuscripts may include primary (original) data.
• Perspective or General Commentaries on methods and protocols relevant for Pharmacology of Anti-Cancer Drugs research.
• Reviews and mini-reviews of topical methods and protocols highlighting the important future directions of the field.
For more information on the description and formats of the different article types please see here
This Research Topic is part of the Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021 series.
Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021
Methods and Application in Cardiovascular and Smooth Muscle Pharmacology: 2021
Methods and Application in Integrative and Regenerative Pharmacology: 2021
Methods and Application in Drug Metabolism and Transport: 2021
Methods and Application in Predictive Toxicology: 2021
Please submit your article to the Research Topic that best suits the focus of your research.
Introduction and general guidelines
This series aims to highlight the latest experimental techniques and methods used to investigate fundamental questions in Pharmacology of Anti-Cancer Drugs research from drugs targeting tumor cells to components of the tumor microenvironment, including non-tumor cells (e.g., endothelial cells, macrophages, lymphocytes, and fibroblasts), and stress conditions such as hypoxia and acidity. This collection may include the synergy between chemotherapy and targeted therapies including immunotherapies (e.g. CAR-T cells); the use of nanoscale particles or targeting moieties to improve drug bioavailability; the role of extracellular vesicles, liquid biopsies as platelets; the identification of biomarkers derived from proteomics, genomics or imaging technologies to predict response or resistance to drug treatment. Review articles or opinions on methodologies or applications including the advantages and limitations of each are welcome. This Topic includes technologies and up-to-date methods which help advance science.
The contributions to this collection will undergo peer-review. Novelty may vary, but the utility of a method or protocol must be evident. We welcome contributions covering all aspects of Pharmacology of Anti-Cancer Drugs. Submissions will be handled by the team of Topic Editors in the respective sections.
Frontiers in Pharmacology supports the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles for scientific data management and stewardship (Wilkinson et al., Sci. Data 3:160018, 2016).
This Research Topic welcomes:
• Methods: Describing either new or existing methods that are significantly improved or adapted for specific purposes. These manuscripts may include primary (original) data.
• Perspective or General Commentaries on methods and protocols relevant for Pharmacology of Anti-Cancer Drugs research.
• Reviews and mini-reviews of topical methods and protocols highlighting the important future directions of the field.
For more information on the description and formats of the different article types please see here
Keywords: Pharmacology, Anti-Cancer Drugs, Methods, Tumor
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
